@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:mjrr9vvj&rows=> .
@prefix ns2: <http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:> .
@prefix ns3: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RA4yvybzMoVIahbLE5y-sohzGnw5JqNcjfJVdc_GiZTns#> .
@prefix this: <http://purl.org/np/RA4yvybzMoVIahbLE5y-sohzGnw5JqNcjfJVdc_GiZTns> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C1518681> ns3:include <https://uts.nlm.nih.gov/uts/umls/concept/C3885145> .
}

sub:provenance {
  sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" .
  
  sub:_version prov:value "2"^^xsd:integer .
  
  sub:assertion prov:generatedAtTime "2023-07-20T09:47:30.674527"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4692-1377;
    prov:wasDerivedFrom <https://www.ncbi.nlm.nih.gov/pubmed/33907514/> .
  
  rdf:OBJECT rdfs:label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," .
  
  rdf:OBJECT-POSITION rdfs:label "(41, 47)" .
  
  rdf:PREDICATE rdfs:label "including" .
  
  rdf:PREDICATE-POSITION rdfs:label "105" .
  
  rdf:SUBJECT rdfs:label "the potential Treg-boosting effect of" .
  
  rdf:SUBJECT-POSITION rdfs:label "(41, 47)" .
  
  rdf:Statement rdfs:label "Furthermore, the potential Treg-boosting effect of therapeutic agents used in the treatment of COVID-19, including dexamethasone, vitamin D, tocilizumab and sarilumab, chloroquine, hydroxychloroquine, azithromycin, adalimumab and tetrandrine, is discussed." .
  
  rdfs:ABSTRACT-UID ns1:50 "mjrr9vvj" .
  
  rdfs:TRIPLE-UID ns2:mjrr9vvj-TRIPLE-ABSTRACT-3 "mjrr9vvj-TRIPLE-ABSTRACT-3" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C1518681> rdfs:label "effect" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C3885145> rdfs:label "sarilumab" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "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";
    npx:hasSignature "KLGY+pTALBPl+74OTRNF7pjTa2ptPeqPHjldH05bjw9+ZdoRypeEmsgAjk70rRE/Eg5KvM06YdNtN1kxW8kURaHJXjv7mv8b/F17TVBc4E1ao/qdLy48vYJOH2FO0lMhHGQFxHYtrZ8xBSHqsZNksV24NZDdsCv2HR9SGYEQfYYkWbq/GTOJhM9lTUbDJJU47M+wppwQW65YH8HFZmsBwGbfoqprwL1dtA/+fIOfJhvzOpx+7Kg2KNH7ZMgesEK9PGEtfKD88paI9e5DUwvhM4bPsLZok29w065GwycW6P1Gtu0MRs1FqhwoXK8is+vS4etLLFLc4Li/z5mZFsjPF6O2R4F+Y/mMgXFiiWZRBFJm7xwwSMrh37dsCHv9z9czP5XWgr+UiQvS9nWW5frMdisfEsM6CVe8G+UryhzOaJ/q3OmMK5eVJJqvZuIbK4cE8gcE4BybVfvShnlmt2qmm+t3WLttZzZOqTKtrt/hj5/Jf2qIgAwHrogr7y4WHCpX";
    npx:hasSignatureTarget this: .
  
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}